Related Experiment Video
Updated: Feb 8, 2026

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
Published on: January 26, 2019
Thymoquinone challenges UHRF1 to commit auto-ubiquitination: a key event for apoptosis induction in cancer cells
Abdulkhaleg Ibrahim1,2, Mahmoud Alhosin3,4, Christophe Papin1
1Institut De Génétique Et De Biologie Moléculaire Et Cellulaire (IGBMC), INSERM U1258 CNRS UMR 7104, Université de Strasbourg, Illkirch, France.
Abstract:
Down-regulation of UHRF1 (Ubiquitin-like containing PHD and Ring Finger 1) in Jurkat cells, induced by natural anticancer compounds such as thymoquinone, allows re-expression of tumor suppressor genes such as p73 and p16 . In order to decipher the mechanisms of UHRF1 down-regulation, we investigated the kinetic of expression of HAUSP (herpes virus-associated ubiquitin-specific protease), UHRF1, cleaved caspase-3 and p73 in Jurkat cells treated with thymoquinone. We found that thymoquinone induced degradation of UHRF1, correlated with a sharp decrease in HAUSP and an increase in cleaved caspase-3 and p73. UHRF1 concomitantly underwent a rapid ubiquitination in response to thymoquinone and this effect was not observed in the cells expressing mutant UHRF1 RING domain, suggesting that UHRF1 commits an auto-ubiquitination through its RING domain in response to thymoquinone treatment. Exposure of cells to Z-DEVD, an inhibitor of caspase-3 markedly reduced the thymoquinone-induced down-regulation of UHRF1, while proteosomal inhibitor MG132 had no such effect. The present findings indicate that thymoquinone induces in cancer cells a fast UHRF1 auto-ubiquitination through its RING domain associated with HAUSP down-regulation. They further suggest that thymoquinone-induced UHRF1 auto-ubiquitination followed by its degradation is a key event in inducing apoptosis through a proteasome-independent mechanism.
Insights
Thymoquinone triggers cancer cell apoptosis by causing rapid auto-ubiquitination and degradation of UHRF1 (Ubiquitin-like containing PHD and Ring Finger 1) via a caspase-3 dependent pathway.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- UHRF1 (Ubiquitin-like containing PHD and Ring Finger 1) down-regulation by natural compounds like thymoquinone can restore tumor suppressor gene expression.
- Understanding the precise mechanisms of UHRF1 regulation is crucial for developing novel cancer therapies.
Purpose of the Study:
- To investigate the molecular mechanisms by which thymoquinone induces UHRF1 down-regulation in Jurkat cells.
- To elucidate the role of HAUSP, caspase-3, and UHRF1 auto-ubiquitination in this process.
Main Methods:
- Kinetic analysis of HAUSP, UHRF1, cleaved caspase-3, and p73 expression in Jurkat cells treated with thymoquinone.
- Assessment of UHRF1 ubiquitination using a mutant UHRF1 RING domain.
- Evaluation of UHRF1 down-regulation in the presence of caspase-3 inhibitor (Z-DEVD) and proteasomal inhibitor (MG132).
Main Results:
- Thymoquinone treatment led to UHRF1 degradation, decreased HAUSP levels, and increased cleaved caspase-3 and p73.
- UHRF1 underwent rapid auto-ubiquitination through its RING domain in response to thymoquinone, a process dependent on caspase-3 activity.
- Proteasomal degradation was not involved in thymoquinone-induced UHRF1 down-regulation.
Conclusions:
- Thymoquinone induces rapid UHRF1 auto-ubiquitination and degradation in cancer cells via a caspase-3 dependent, proteasome-independent pathway.
- This mechanism, involving HAUSP down-regulation, is a key event in thymoquinone-induced apoptosis.
More Related Videos
Related Concept Videos
Lineage Commitment
Apoptosis
Key Techniques in Microbiology
Key Elements for Plant Nutrition
Integration of Synaptic Events
Induction
A...

